Income Statement
COYA THERAPEUTICS, INC.
COYA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
7.95 | 3.55 | 6.00 | - |
|
Cost of Revenue
|
- | - | - | - |
|
Gross Profit
|
7.95 | 3.55 | 6.00 | - |
|
Operating Expenses
|
30.50 | 20.80 | 13.91 | 9.81 |
|
Research & Development
|
16.73 | 11.87 | 5.50 | 4.41 |
|
Selling, General & Administrative
|
11.45 | 8.89 | 7.83 | 4.85 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-22.56 | -17.25 | -7.90 | -9.81 |
|
Non-Operating Income
|
-1.33 | -1.65 | -0.64 | - |
|
Interest Income
|
- | - | - | - |
|
Interest Expense
|
- | - | - | - |
|
Other Non-Op Income / Expense
|
1.33 | 1.65 | 0.64 | 0.06 |
|
Income Before Tax
|
-21.20 | -15.60 | -7.26 | - |
|
Income Tax Expense
|
0.00 | -0.72 | 0.72 | - |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
-21.23 | -14.88 | -7.99 | -12.24 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-22.56 | -17.25 | -7.90 | -9.81 |
|
Earnings Per Share (Basic)
|
-1.27 | -0.98 | -0.79 | -4.73 |
|
Diluted EPS
|
-1.27 | -0.98 | -0.79 | -4.73 |
|
Weighted Average Shares
|
16.73 | 15.24 | 10.16 | 2.59 |
|
Diluted Weighted Avg Shares
|
16.73 | 15.24 | 10.16 | 2.59 |
|
Comprehensive Income
|
- | - | - | - |